Apr. 10, 2018—New findings highlight microRNAs — molecules that regulate gene expression — that are differentially expressed in glaucoma and could be candidate biomarkers or targets for therapy.
Sep. 27, 2012—Three Vanderbilt University Medical Center faculty members have been awarded grants from the American Health Assistance Foundation to support their research on glaucoma and macular degeneration — the two leading causes of irreversible blindness in the world.
Feb. 24, 2011—Researchers have identified a new candidate gene for the most common form of glaucoma, which runs in families. The findings offer novel insights into glaucoma pathology and could lead to targeted treatment strategies.